BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31154142)

  • 1. Stepwise pH-sensitive and biodegradable polypeptide hybrid micelles for enhanced cellular internalization and efficient nuclear drug delivery.
    Qu J; Peng S; Wang R; Yang ST; Zhou QH; Lin J
    Colloids Surf B Biointerfaces; 2019 Sep; 181():315-324. PubMed ID: 31154142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stepwise dual pH and redox-responsive cross-linked polypeptide nanoparticles for enhanced cellular uptake and effective cancer therapy.
    Qu J; Wang R; Peng S; Shi M; Yang ST; Luo JB; Lin J; Zhou QH
    J Mater Chem B; 2019 Dec; 7(45):7129-7140. PubMed ID: 31663585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction/temperature/pH multi-stimuli responsive core cross-linked polypeptide hybrid micelles for triggered and intracellular drug release.
    Qu J; Wang QY; Chen KL; Luo JB; Zhou QH; Lin J
    Colloids Surf B Biointerfaces; 2018 Oct; 170():373-381. PubMed ID: 29940504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-pH Sensitive Charge-Reversal Polypeptide Micelles for Tumor-Triggered Targeting Uptake and Nuclear Drug Delivery.
    Han SS; Li ZY; Zhu JY; Han K; Zeng ZY; Hong W; Li WX; Jia HZ; Liu Y; Zhuo RX; Zhang XZ
    Small; 2015 Jun; 11(21):2543-54. PubMed ID: 25626995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charge reversible and biodegradable nanocarriers showing dual pH-/reduction-sensitive disintegration for rapid site-specific drug delivery.
    Miao Y; Qiu Y; Yang W; Guo Y; Hou H; Liu Z; Zhao X
    Colloids Surf B Biointerfaces; 2018 Sep; 169():313-320. PubMed ID: 29800906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface charge switchable nano-micelle for pH/redox-triggered and endosomal escape mediated co-delivery of doxorubicin and paclitaxel in treatment of lung adenocarcinoma.
    Wang QY; Yali-Xiang ; Hu QH; Huang SH; Lin J; Zhou QH
    Colloids Surf B Biointerfaces; 2022 Aug; 216():112588. PubMed ID: 35623260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.
    Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN
    Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
    Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of pH-sensitive zwitterionic nano micelles and drug controlled release for enhancing cellular uptake.
    Wu L; Ni C; Zhang L; Shi G
    J Biomater Sci Polym Ed; 2016; 27(7):643-56. PubMed ID: 26813767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stepwise pH/reduction-responsive polymeric conjugates for enhanced drug delivery to tumor.
    Yang S; Wang Y; Ren Z; Chen M; Chen W; Zhang X
    Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():234-243. PubMed ID: 29025653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparations and doxorubicin controlled release of amino-acid based redox/pH dual-responsive nanomicelles.
    Ding Y; Zhang L; Shi G; Sang X; Ni C
    Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():920-926. PubMed ID: 28532112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
    Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
    Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable phosphorylcholine-based zwitterionic polymer nanogels with smart charge-conversion ability for efficient inhibition of tumor cells.
    Peng S; Men Y; Xie R; Tian Y; Yang W
    J Colloid Interface Sci; 2019 Mar; 539():19-29. PubMed ID: 30572286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepwise targeted drug delivery to liver cancer cells for enhanced therapeutic efficacy by galactose-grafted, ultra-pH-sensitive micelles.
    Yan G; Wang J; Hu L; Wang X; Yang G; Fu S; Cheng X; Zhang P; Tang R
    Acta Biomater; 2017 Mar; 51():363-373. PubMed ID: 28087485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy.
    Kuang Y; Chen H; Chen Z; Wan L; Liu J; Xu Z; Chen X; Jiang B; Li C
    Colloids Surf B Biointerfaces; 2019 Sep; 181():461-469. PubMed ID: 31176118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-sensitive doxorubicin-conjugated prodrug micelles with charge-conversion for cancer therapy.
    Ma B; Zhuang W; Wang Y; Luo R; Wang Y
    Acta Biomater; 2018 Apr; 70():186-196. PubMed ID: 29452272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pH and reduction dual-sensitive polymeric nanomicelle for tumor microenvironment triggered cellular uptake and controlled intracellular drug release.
    Su Z; Xu Y; Wang Y; Shi W; Han S; Shuai X
    Biomater Sci; 2019 Aug; 7(9):3821-3831. PubMed ID: 31268075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile construction of dual-bioresponsive biodegradable micelles with superior extracellular stability and activated intracellular drug release.
    Chen W; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
    J Control Release; 2015 Jul; 210():125-33. PubMed ID: 25987525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,2'-Dithiodisuccinic acid-stabilized polyion complex micelles for pH and reduction dual-responsive drug delivery.
    Du Y; Yan W; Lian H; Xiang C; Duan L; Xiao C
    J Colloid Interface Sci; 2018 Jul; 522():74-81. PubMed ID: 29579564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sericin nanomicelles with enhanced cellular uptake and pH-triggered release of doxorubicin reverse cancer drug resistance.
    Guo W; Deng L; Yu J; Chen Z; Woo Y; Liu H; Li T; Lin T; Chen H; Zhao M; Zhang L; Li G; Hu Y
    Drug Deliv; 2018 Nov; 25(1):1103-1116. PubMed ID: 29742945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.